SLC7A11-HSPB1 Axis: A Novel Mechanism for Hepatocellular Carcinoma Progression and Ferroptosis Regulation. (PubMed, Biomed J) - May 9, 2025 - "SLC7A11 plays a significant role in HCC progression by inhibiting ferroptosis, and its interaction with HSPB1 is a critical pathway in this process. Targeting the SLC7A11-HSPB1 axis may provide a novel therapeutic strategy for HCC treatment, highlighting the importance of understanding the mechanisms of ferroptosis in cancer cells."
Journal • Hepatocellular Cancer • Oncology • Solid Tumor • HSPB1 • SLC7A11
|
|
Jian Huang; Wanqiu Huang; Weilong Liu; Yan An; Yuliang Deng
|